An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular Carcinoma

NCT03439761 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: PT-112 Injection

Sponsor

SciClone Pharmaceuticals